Retina Vitreous Associates, Inc.

Retina Vitreous Associates (RVA) is a specialized medical practice focused on diagnosing and treating retinal diseases and conditions using advanced surgical techniques and technologies. Retina Vitreous Associates, Inc. , founded in 1974, is based in Toledo, US. The company focuses exclusively on retinal care, providing comprehensive services for a variety of retinal disorders.

It was acquired by CEI Vision Partners, LLC, in January 2019. No specific details about the founder's history are provided, nor are there mentions of subsidiaries or pivots in business strategy. Retina Vitreous Associates specializes in high-quality eye care for retinal diseases, including diabetic retinopathy and macular degeneration. Their services involve diagnosis and treatment, performed by board-certified vitreoretinal surgeons using state-of-the-art technology.

RVA mainly serves patients across Toledo, Lima, and Findlay, Ohio, often referred by optometrists and ophthalmologists, and is actively involved in clinical research to enhance their treatment offerings. RVA generates revenue through direct patient care services, including consultations and surgical procedures for retinal conditions. They bill patients or their insurance providers for these services, focusing on B2C interactions. While specific pricing details are not disclosed, the firm's revenue structure reflects the costs associated with advanced surgical techniques and comprehensive eye care, fostering sustained relationships with clients.

Retina Vitreous Associates aims to enhance its service offerings by advancing its research initiatives and exploring new treatment methods. Following the acquisition by CEI Vision Partners, LLC, the company is positioned to expand its operations. The financial terms of the acquisition were not disclosed, indicating potential strategies for future investment and growth.